Neurosciences

< Back

Overview

The Neuroscience area is consolidating its position as one of the largest clusters of research labs working on neurological diseases across Europe. Thirteen groups are currently part of this area, working closely with top clinicians at the hospital. The area encompasses different aspects related to neuroscience, such as neural development, neurodegeneration, neuroimmunology, neurological pain, mental health, neurosurgery or pediatric neurology.

There are groups also focused on cell signaling and apoptosis and translational bioinformatics.

Publications

183
total
815.974
impact factor
4.459
average impact factor

Director: Josep Gámez

The Peripheral Nervous System group has been recognized in 2017 as the ERN center for Rare Neuromuscular Diseases (EURO-NMD) and as ERN center for Rare Neurological Diseases (EURO – RND), exceptionally distinguished by two different European networks.

Consequently, the research line in Translational Medicine has identified two drugs against Miastenia Gravis (Lancet Neurol. 2017 et. J. Neurol. Sci 2017), one of which has already been approved by the FDA. This same project defined the first Spanish family with an ultra-rare variant of the CMT provoked by mutations at the SBF1 gene.

A research line designed and developed fully at Barcelona’s Vall d’Hebron Hosptial Campus, has led to the discovery of the impacts and effects of early neurological complications in patients that have gone through a pulmonary transplant.

VHIR Annual Report 2017